Daiichi Sankyo
Manufacturing · Japan · 10K+ Employees
View Company Info for Free
Overview
Headquarters
3-5-1 Nihonbashi-honcho Chuo-ku, Tokyo, ...Phone Number
+81 362251111Website
www.daiichisankyo.comRevenue
$12.8 BillionStock Symbol
4568Industry
About Daiichi Sankyo
Daiichi Sankyo Org Chart
Is Daiichi Sankyo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Daiichi Sankyo had a recent Job posting/layoffs
Product Launch: Get notified when Daiichi Sankyo launches new products
Earning: See what the market has to say on Daiichi Sankyo recently announced quarterly report
Website visits: Recent activity has been detected on your website
Daiichi Sankyo, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Daiichi Sankyo
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Daiichi Sankyo has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Daiichi Sankyo has new funding data
Check out if Daiichi Sankyo is spiking on competitors!
Recommended Actions
Find VP level buyers at Daiichi Sankyo
Find more new buyers
Compare Similar Companies to Daiichi Sankyo
Compare insights from companies similar to Daiichi Sankyo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Daiichi Sankyo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Daiichi Sankyo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Daiichi Sankyo.
Daiichi Sankyo Tech Stack
A closer look at the technologies used by Daiichi Sankyo
Most Recent Scoops
Daiichi Sankyo News & Media
Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership ...
Read and download our press releases.Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies
PETACH TIKVA, Israel, April 16, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical stage biotechnology company advancing its Molecular Nano Motor (MNM) intracellular delivery platform, today announced a research collaboration with Daiichi Sankyo (TSE: 4568) through its Daiichi Sankyo...Did EMA's ENHERTU Validation and Leadership Changes Just Reframe Daiichi Sankyo's ...
In February 2026, Daiichi Sankyo received European Medicines Agency validation to expand the indication of ENHERTU for HER2 positive early breast cancer, while also announcing leadership transitions including a new Global Head of R&D and upcoming changes to its board and audit members. These developments, alongside a new AI-driven collaboration with BostonGene and ongoing litigation linked to past disputes, highlight how Daiichi Sankyo is reshaping its oncology innovation engine and...Ex-Novartis CMO John Tsai joins Daiichi Sankyo | pharmaphorum
Daiichi Sankyo has named John Tsai as its new chief medical officer, replacing Ken Takeshita, who is stepping down after five years in the role.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Daiichi Sankyo
Founded in 2005, Headquartered in Tokyo, Daiichi Sankyo is a global pharmaceutical company that develops and provides innovative new and generic medicines, as well as advanced drug discovery and delivery methods, serving patients in over 30 countries.... Read More
